Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036.
Cancer Cell. 2011 Apr 12;19(4):556-68. doi: 10.1016/j.ccr.2011.03.003.
Cancer Cell. 2011.
PMID: 21481795
Free PMC article.
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.
Smith BD, Kaufman MD, Lu WP, Gupta A, Leary CB, Wise SC, Rutkoski TJ, Ahn YM, Al-Ani G, Bulfer SL, Caldwell TM, Chun L, Ensinger CL, Hood MM, McKinley A, Patt WC, Ruiz-Soto R, Su Y, Telikepalli H, Town A, Turner BA, Vogeti L, Vogeti S, Yates K, Janku F, Abdul Razak AR, Rosen O, Heinrich MC, Flynn DL.
Smith BD, et al. Among authors: ensinger cl.
Cancer Cell. 2019 May 13;35(5):738-751.e9. doi: 10.1016/j.ccell.2019.04.006.
Cancer Cell. 2019.
PMID: 31085175
Free article.
Item in Clipboard
Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2.
Smith BD, Kaufman MD, Leary CB, Turner BA, Wise SC, Ahn YM, Booth RJ, Caldwell TM, Ensinger CL, Hood MM, Lu WP, Patt TW, Patt WC, Rutkoski TJ, Samarakoon T, Telikepalli H, Vogeti L, Vogeti S, Yates KM, Chun L, Stewart LJ, Clare M, Flynn DL.
Smith BD, et al. Among authors: ensinger cl.
Mol Cancer Ther. 2015 Sep;14(9):2023-34. doi: 10.1158/1535-7163.MCT-14-1105. Epub 2015 Aug 18.
Mol Cancer Ther. 2015.
PMID: 26285778
Item in Clipboard
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region.
Ahn YM, Clare M, Ensinger CL, Hood MM, Lord JW, Lu WP, Miller DF, Patt WC, Smith BD, Vogeti L, Kaufman MD, Petillo PA, Wise SC, Abendroth J, Chun L, Clark R, Feese M, Kim H, Stewart L, Flynn DL.
Ahn YM, et al. Among authors: ensinger cl.
Bioorg Med Chem Lett. 2010 Oct 1;20(19):5793-8. doi: 10.1016/j.bmcl.2010.07.134. Epub 2010 Aug 3.
Bioorg Med Chem Lett. 2010.
PMID: 20800479
Item in Clipboard
A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site.
VanAtten MK, Ensinger CL, Chiu AT, McCall DE, Nguyen TT, Wexler RR, Timmermans PB.
VanAtten MK, et al. Among authors: ensinger cl.
J Med Chem. 1993 Dec 10;36(25):3985-92. doi: 10.1021/jm00077a001.
J Med Chem. 1993.
PMID: 8258820
Item in Clipboard
Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists.
Peng H, Kumaravel G, Yao G, Sha L, Wang J, Van Vlijmen H, Bohnert T, Huang C, Vu CB, Ensinger CL, Chang H, Engber TM, Whalley ET, Petter RC.
Peng H, et al. Among authors: ensinger cl.
J Med Chem. 2004 Dec 2;47(25):6218-29. doi: 10.1021/jm0494321.
J Med Chem. 2004.
PMID: 15566292
Item in Clipboard
Prodrugs to improve the oral bioavailability of a diacidic nonpeptide angiotensin II antagonist.
Aungst BJ, Blake JA, Rogers NJ, Saitoh H, Hussain MA, Ensinger CL, Pruitt JR.
Aungst BJ, et al. Among authors: ensinger cl.
Pharm Res. 1995 May;12(5):763-7. doi: 10.1023/a:1016228129729.
Pharm Res. 1995.
PMID: 7479565
Item in Clipboard
Syntheses and biological evaluation of vinblastine congeners.
Kuehne ME, Bornmann WG, Markó I, Qin Y, LeBoulluec KL, Frasier DA, Xu F, Mulamba T, Ensinger CL, Borman LS, Huot AE, Exon C, Bizzarro FT, Cheung JB, Bane SL.
Kuehne ME, et al. Among authors: ensinger cl.
Org Biomol Chem. 2003 Jun 21;1(12):2120-36. doi: 10.1039/b209990j.
Org Biomol Chem. 2003.
PMID: 12945903
Item in Clipboard
Cite
Cite